Newsletters

Take a look at the main highlights from BioMed Alliance and EU-level developments in September 2026. This edition covers the BioMed Alliance General Assembly 2026, BioMed Alliance recommendations on the Biotech Act, an update on EU Pharmaceutical Legislation, new COMBINE programme guidance on safety reporting, an update on BioMed Alliance’s HTA work, and updated MDCG guidance on IVD MD classification.

Take a look at the main highlights from BioMed Alliance and EU-level developments in August 2026. This edition covers BioMed Alliance’s response to the European Commission consultation on the EU Biotech Act proposal, the recruitment of experts for medical device and in vitro diagnostics expert panels (EXPAMED), and new tools and guidance on Joint Clinical Assessments under the EU Health Technology Assessment (HTA) framework. It also looks at new EU transparency rules for AI systems, Japan joining Horizon Europe, and the BRIDGE survey on regulatory sandboxes in European healthcare.

Take a look at the main highlights from BioMed Alliance and EU-level developments in July 2026. This edition includes a brief recap of the BioMed Alliance Clinical Trials Workshop, the BioMed Alliance response to the European Commission’s call for evidence on European Partnerships in Health Research, the EMA’s updated CTIS Sponsor Handbook, the European Commission’s Action Plan on Cybersecurity and Artificial Intelligence, the EnprEMA consultation on cross-border access to paediatric clinical trials and the White Book on paediatric research awareness.

Take a look at the main highlights from BioMed Alliance and EU-level developments in June 2026. This edition covers our upcoming clinical trials workshop, a Spring Meeting recap, healthcare professionals’ views on the MDR/IVDR revision, a joint MFF letter calling for a strong EU health budget, feedback to the EDPB on GDPR research guidelines, a Horizon Europe consultation on Joint Undertakings, and the COMBINE Phase 2 programme. You will also find information on upcoming events.

Take a look below at the main highlights for BioMed Alliance and EU-level developments in May 2026. This edition includes updates on the upcoming Spring Meeting, the Critical Medicines Act (CMA), health data policy, the Global Health Resilience Initiative, EMA’s breakthrough medical devices pilot, the EU consultation on tobacco control, and EU4Health priorities. You can also find information on upcoming events.

Take a look below at the main highlights for BioMed Alliance and developments at the EU level in April 2026. This edition includes updates on BioMed’s position statement for the next Horizon Europe (FP10) regulation proposal, a recap of our ‘Digital Transformation in Healthcare’ workshop, and other relevant health policy updates. We also feature members’ news and information about upcoming events.

Take a look below at the main highlights for the BioMed Alliance and developments at EU level in March 2026. In this edition, you’ll find updates on BioMed’s MDR & IVDR advocacy activities, recommendations on the Digital Omnibus proposal, the European Parliament event on Reducing Bureaucracy in Clinical Trials, the BioMed statement on the Critical Medicines Act, an update on the new EU Gender Equality Strategy (2026-2030), the EU call for evidence on the Global Health Resilience Initiative, the More-EUROPA survey on patient registries in EU medicines decision-making, a consultation on the Cybersecurity Package, as well as members’ news and information about other upcoming events.

Take a look below at the main highlights for the BioMed Alliance and developments at EU level in February 2026. In this edition, you will find an update on medical education activities, details about our breakout session at the European Commission’s High-Level Conference on Medical Devices and IVDs, information on the FAST-EU pilot project, an update on ongoing discussions on the European Competitiveness Fund (ECF) in the European Parliament, updates on the 2026 Horizon Europe health calls for proposals, an announcement of the BioMed Spring Meeting 2026, members’ news, and information on other upcoming events.

Take a look below at the main highlights for the BioMed Alliance and developments at EU level in January 2026. In this first edition of the year, you will find updates on BioMed MDR & IVDR advocacy activities, recommendations from the Bureaucracy in Clinical Trials Coalition, the European Commission implementing act designating new reference laboratories for high-risk IVDs, the political agreement on the reform of EU pharmaceutical legislation, and the Commission’s Safe Hearts Plan. You will also find information on the open consultation for the Action Plan for Women in Research, Innovation, and Startups, the IHI call for innovative health projects, and upcoming events.